Objectives Implanon ® was introduced in the UK in September 1999. We present here the results of our first 106 Implanon insertions, performed over a period of 18 months. The aims of the study were to study the clinical and demographic profile of Implanon users, to assess the continuation rates of Implanon in the local population, and to identify the reasons for removal.
Introduction
Implanon ® has several advantages over other methods of contraception including high efficacy, the need for minimal maintenance, absence of oestrogen, and rapid return of fertility after discontinuation. It was introduced in the UK in September 1999. Because of its relatively recent introduction, there have been no published studies in the UK to date investigating the continuation rates of a sample of users for a full 3-year period until recommended removal. We present here our findings of the first 106 Implanon insertions performed between January 2000 and July 2001, which were followed until 31 July 2004. The objectives of this study were three-fold: (1) to study the clinical and demographic profile of Implanon users, (2) to assess the continuation rates of Implanon in the local population and (3) to identify the reasons for removal.
Methods
This was a case note-based study, which was conducted at the Family Planning and Reproductive Health Care Centre, Luton Primary Care Trust (PCT), Luton, UK. The project proposal was submitted to the Evidence-Based Practice Group of Luton PCT and was approved. The project proposal was subsequently modified and resubmitted when it was realised that some of the clients did not return for removal of their Implanon after the 3-year expiry date. The option of writing to or phoning these clients or their general practitioner (GP) was considered but it was decided not to do so in view of lack of prior consent from clients and also due to the fear of potential breach of confidentiality.
Between January 2000 and July 2001, 106 clients had an Implanon device fitted by our service. We followed this group of clients until July 2004 so that each of them could complete the full 3-year period.
The demographic and clinical profile of Implanon users (e.g. age, ethnicity, parity, smoking status, medical and contraceptive history, weight at insertion and removal, date of insertion and removal, and reasons for removal) were collected from the case notes. The data were transferred to a standardised pre-tested proforma. The data were analysed using Microsoft Excel and SPSS v.12 (SPSS Inc., Chicago IL, USA).
Results
Of the 106 clients who commenced Implanon, 86 have had their device removed in this time period. The Implanon status of the remaining 20 is unknown since they were lost to follow-up by our service. Therefore, the demographic profile relates to 106 clients, whereas the continuation rates and reasons for removal relate to 86 clients.
The age range of the 106 Implanon users was 15-43 (mean, 25.2) years and 36.8% were nulliparous. The preinsertion weight exceeded 70 kg in 41% of cases. Some 67% of clients were white Caucasian women, 17% were Asian and 16% belonged to other ethnic groups. Eighty-six of these clients had their Implanon removed. Twenty (18.9%) clients were lost to follow-up by our service, which means they did not return to our service for Implanon removal after the 3-year expiry period. Of these 86 cases, 26 completed the full 3-year period; therefore, the continuation rate at 3 years was 30.2%. The continuation rates at 1 and 2 years were 69.8% (60 cases) and 44.1% J Fam Plann Reprod Health Care 2005: 31(4) ARTICLE (38 cases), respectively. Of the 26 women who had their Implanon in place for 3 years, 16 (61.5%) had their Implanon replaced with a new one. Two clients retained their devices for 3 and 8 months, respectively, beyond the device's expiry date as they could not remember the planned removal date, but still there was no failure of the method.
Of the 60 cases with Implanon removal before the recommended 3-year period, the most common reason for removal was for bleeding irregularity, which occurred in 24 (40%) cases. Other reasons for removal were to plan pregnancy (nine cases, 15%), mood swings and weight gain (six cases, 10% each), contraception no longer required (four cases, 6.7%), amenorrhoea (two cases, 3.3%) and other reasons (nine cases, 15%). No failure of the method was found with Implanon use even though 40 (37.7%) women were in the 70-100 kg weight range and four (3.8%) exceeded 100 kg.
Discussion

Demographic profile
The age range of the 106 Implanon users was 15-43 (mean, 25.2) years and 36.8% were nulliparous. These observations are similar to the observations made by Rai et al. 1 who found a mean age of 25 years with 36% being nulliparous women. The mean weight gain was 3.15 (range, -14 to +23, SD 6.48) kg. This is comparable to observations made by Davies et al. 2 who reported a 3.7 kg weight gain (maximum 22 kg, minimum 1.5 kg) by the end of the first treatment year.
The ethnic origin of those using Implanon was similar to the ethnic mix of the overall family planning clinic attendees at Luton.
Continuation rate
Our continuation rates at 1, 2 and 3 years were 69.8%, 44.1% and 30.2%, respectively. Edwards and Moore 3 reported an overall continuation rate of 82% for Implanon use for 24 months. However, it should be borne in mind that this continuation rate was for a clinical trial population and not for a clinic population as in the present study.
To date, the other published studies based on real-life situations have provided only estimates of continuation rates for Implanon use. 1, 4 Efficacy All clients weighing above 100 kg were advised to have their Implanon removed at 2.5 years. 5 Four clients' weight exceeded 100 kg. Two cases had early removal, but the other two had removal after 2.5 and 3 years and also had immediate reinsertion of another Implanon device. There are some concerns about contraceptive efficacy for women weighing over 100 kg; although we had only two cases in our study, no failure of the method occurred.
Data from studies undertaken during the development of Implanon 6 included a core dataset of 13 studies that met the requirements for good clinical practice. These studies, involving 1716 women in at least 10 different countries, contributed 4103 woman-years of use of Implanon in which no pregnancies occurred. The reported failure rate of Implanon was therefore zero. There are insufficient data on the influence of age and weight on the effectiveness of this contraceptive device. 7 
Reasons for removal
Of the 60 cases with Implanon removal before the recommended 3-year period, the most common reason for removal was bleeding irregularity (40.0%). Other reasons for removal were planned pregnancy (15%), mood swings and weight gain (10% each), contraception no longer required (6.7%), amenorrhoea (3.3%) and other reasons (15%).
The above findings are comparable to observations made by Smith and Reuter 4 who reported reasons for removal as bleeding problems (34%), mood swings (24%), weight gain (12%), planned pregnancy (10%) and other reasons (27%); however, their study did not follow a cohort for a full 3-year period.
In Europe, the discontinuation rates due to vaginal bleeding pattern disturbances in comparative trials were 30.2% for Implanon and 22.5 % for Norplant ® . 8 All studies to date show that irregular bleeding is the most common reason for discontinuation. This is understandable since unpredictable and prolonged vaginal bleeding can be a considerable nuisance and can adversely affect women's daily lives.
Insertion or removal complications
Edwards and Moore, 3 in a review of clinical studies of Implanon, noted complications of Implanon insertion in 0.6% (10/1716) in all studies; these complications involved mainly bleeding at the insertion site or failure of the implant device. They also reported complications of Implanon removal in 1.3% (12/1616) of women in all studies. The 21 complications involved six deep insertions, six with fibrous adhesions, four where there was difficulty finding the implant, three broken implants and two other problems. 3 In the present study we did not notice any insertion or removal complications except in one case where the Implanon snapped spontaneously in situ 3 months before its expiry period. The client knew the Implanon had broken but was unperturbed by this fact. She attended 2 months later for removal as well as reinsertion of a new device. The removal procedure was uncomplicated except that the Implanon had to be removed in two pieces. To the best of our knowledge, this is the first case of an Implanon device snapping into two halves spontaneously in situ. 9 The only other case reported in the literature is one in which an Implanon device had fractured halfway across its width during a game of 'rough and tumble'. 10 
Limitations of the present study
As mentioned earlier, 20 clients were lost to follow-up. We speculate that this may be attributed to the movement of the population to and from the Luton area. Because of the lack of prior consent from clients, and also due to the fear of 
